Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,608 | -16 | -57 | -2 | N/A |
| Depreciation Amortization | 59 | 1 | 1 | 0 | N/A |
| Other Working Capital | 22 | 0 | -4 | 5 | N/A |
| Other Operating Activity | 907 | 15 | 0 | 0 | 0 |
| Operating Cash Flow | $-621 | $0 | $-60 | $3 | $N/A |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | N/A | N/A | N/A | -4 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -4 | 0 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-4 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,910 | N/A | N/A | 61 | N/A |
| Other Financing Activity | -5 | 20 | 3 | 0 | 0 |
| Financing Cash Flow | $1,905 | $20 | $3 | $61 | $N/A |
| Beginning Cash Position | 8 | 3 | 60 | 0 | N/A |
| End Cash Position | 1,293 | 8 | 3 | 60 | N/A |
| Net Cash Flow | $1,284 | $5 | $-57 | $60 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -621 | 0 | -60 | 3 | N/A |
| Free Cash Flow | -621 | 0 | -60 | 3 | 0 |